STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT04963946 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04963946
- Sponsor
- French Innovative Leukemia Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2025-08-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.